Dovato is a brand-name prescription medication used to treat HIV-1 infection in adults and adolescents who have not previously been treated for HIV [1]. It is a combination of two antiretroviral drugs: dolutegravir and lamivudine [2].
What is Dovato's active ingredient?
Dovato contains the active ingredients dolutegravir and lamivudine. Dolutegravir is an integrase strand transfer inhibitor, and lamivudine is a nucleoside analog reverse transcriptase inhibitor [2].
How does Dovato work for HIV treatment?
Dovato works by preventing the HIV virus from multiplying in the body. Dolutegravir blocks an enzyme that HIV needs to make copies of itself, while lamivudine interferes with the virus's ability to replicate by acting as a faulty building block [2].
How long does Dovato treatment last?
Treatment duration with Dovato is typically long-term, as it is used for managing chronic HIV infection. The specific length of treatment will depend on individual patient response and physician guidance [1].
What are the common side effects of Dovato?
Common side effects reported with Dovato include headache, diarrhea, nausea, fatigue, and insomnia [1].
Are there any serious side effects associated with Dovato?
Serious side effects can occur with Dovato, including hypersensitivity reactions, liver problems, and lactic acidosis. Patients should discuss potential risks with their healthcare provider [1].
Can Dovato be used in patients with pre-existing conditions?
Dovato's use in patients with pre-existing conditions, such as liver or kidney disease, should be carefully evaluated by a healthcare professional. It may not be suitable for everyone [1].
How does Dovato compare to other HIV treatments?
Dovato is a two-drug regimen, which differs from some other HIV treatments that may involve three or more medications. This can potentially lead to fewer side effects for some patients [2].
What is the recommended dosage for Dovato?
The standard recommended dosage for Dovato is one tablet (containing 50 mg of dolutegravir and 300 mg of lamivudine) taken orally once daily, with or without food [1].
When does Dovato's patent expire?
Patent expiration dates for pharmaceuticals are complex and can involve multiple patents covering different aspects of a drug. Information on specific patent expiries for Dovato can be found through specialized resources [3]. DrugPatentWatch.com provides data on drug patents and their expiry dates [4].
Can generic versions of Dovato be made?
The availability of generic versions of Dovato depends on patent expiry and regulatory approvals. Once patents expire and exclusivity periods end, generic manufacturers may be able to produce and market bioequivalent versions of the drug [4].